Portfolio Clinic‘We’re selling property – how should we invest our £2.5mn?’Portfolio Clinic: Our readers are tired of buy-to-let and have cash to put to work. Taha Lokhandwala takes a lookSave23 January 2026
Alpha Weekly AnalysisMining Greenland is hard – but this Aim stock is ready to rollThe challenging territory might not be an El Dorado for MagaSave23 January 2026
The TraderStocks rise, but so does goldUpdates on world markets and companies newsSave23 January 2026
Alpha Weekly AnalysisTwo quality shares awaiting an earnings liftPhil Oakley asks if these companies on our watchlist are worth backingSave23 January 2026
Results & Trading UpdatesGE Aerospace grows the top line, but at a reduced clipThe engine maker has revealed a marked increase in earnings and cash flowsSave23 January 2026
Results & Trading UpdatesABF weighed down by PrimarkTrading update: Festive sales at Primark fell, and the food business was unable to pick up the slackSave22 January 2026
¹û¶³´«Ã½ of the WeekA rare opportunity to buy a quality stock at a discountThe market is fretting about AI, but this FTSE 100 giant’s competitive moat remains robustSave22 January 2026
Results & Trading UpdatesIlika is in need of a boostSolid-state battery company’s road towards commercialisation is proving to be long and arduousSave22 January 2026
¹û¶³´«Ã½ of the WeekTime to stop ignoring this cash-backed biotechThe Aim-traded stock offers investors the chance to play the big themes in drug developmentSave22 January 2026
The Big ReadThe ‘real’ American stocks where investors can bag a bargainEconomic uncertainty and a focus on AI mean some consumer and industrial stocks are mispriced. We highlight where to lookSave22 January 2026